Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement

por Connelly, Jennifer, Hormigo, Adília, Mohilie, Nimish, Hu, Jethro, Chaudhry, Aafia, Blondin, Nicholas
Publicado 2016

NovoTTF(™)-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL(™) system user study

por Chaudhry, Aafia, Benson, Laura, Varshaver, Michael, Farber, Ori, Weinberg, Uri, Kirson, Eilon, Palti, Yoram
Publicado 2015

Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies

por Mansoor, Wasat, Roeland, Eric J., Chaudhry, Aafia, Liepa, Astra M., Wei, Ran, Knoderer, Holly, Abada, Paolo, Chatterjee, Anindya, Klempner, Samuel J.
Publicado 2021

PB2279: TRIAL IN PROGRESS: ODRONEXTAMAB, A CD20×CD3 BISPECIFIC ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MZL) – A COHORT FROM THE ELM...

por Cho, Seok-Goo, Kim, Tae Min, Taszner, Michał, Chen, Tsai Yun, Chaudhry, Aafia, Ufkin, Melanie, Uppala, Amulya, Sabir, Ayesha, Mohamed, Hesham, Ambati, Srikanth, Bachy, Emmanuel
Publicado 2023

PB2328: TRIAL IN PROGRESS: ATHENA-1 – A PHASE 1 STUDY TO ASSESS SAFETY AND TOLERABILITY OF REGN5837 IN COMBINATION WITH ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE...

por Mutsaers, Pim G. N. J., Abramson, Jeremy S., Namuduri, Manjusha, LI, Jingjin, Sophos, Nickolas A., Zhu, Min, Brouwer-Visser, Jurriaan, Mohamed, Hesham, Chaudhry, Aafia, Davies, Andrew J.
Publicado 2023

PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN...

por Segura, Cecilia Carmen Carpio, Namuduri, Manjusha, Liu, Dishan, Sophos, Nickolas A., Zhu, Min, Sabir, Ayesha, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Garcia-Sancho, Alejandro Martin
Publicado 2023

PB2275: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHEMOTHERAPY VERSUS RITUXIMAB PLUS CHEMOTHERAPY IN PREVIOUSLY UNTREATED FOLLICULAR...

por Novelli, Silvana, Risal, Ashish, Namuduri, Manjusha, Cai, Jingxian, Ufkin, Melanie, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Iskierka-Jażdżewska, Elżbieta
Publicado 2023

PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1)

por Luminari, Stefano, Kim, Tae Min, Risal, Ashish, Namuduri, Manjusha, Cai, Jingxian, Fearon-Chalet, Bertha, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Vitolo, Umberto
Publicado 2023

Complete responses to odronextamab in two patients with diffuse large B‐cell lymphoma refractory to chimeric antigen receptor T‐cell therapy

por Weinstock, Matt, Elavalakanar, Pavania, Bright, Susan, Ambati, Srikanth R., Brouwer‐Visser, Jurriaan, Pourpe, Stephane, Fiaschi, Nathalie, Jankovic, Vladimir, Thurston, Gavin, Deering, Raquel P., Chaudhry, Aafia, Joyce, Robin, Arnason, Jon
Publicado 2022

PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYM...

por Hawkes, Eliza A., Kim, Tae Min, Namuduri, Manjusha, Risal, Ashish, Shen, Biyi, Flink, Dina, Zhu, Min, Nolan, Siobhán, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Ambati, Srikanth, Mohamed, Hesham, Cho, Seok-Goo
Publicado 2023

PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (...

por Tessoulin, Benoit, Guidez, Stephanie, Namuduri, Manjusha, Risal3, Ashish, Waldron, Alpana, Sophos, Nickolas A., Uppala, Amulya, Zhu, Min, Nolan, Siobhán, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Ambati, Srikanth, Mohamed, Hesham, Tucker, David
Publicado 2023

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA...

por Vitolo, Umberto, Phillips, Elizabeth H., Alonso, Aránzazu Alonso, Merli, Michele, Risal, Ashish, Namuduri, Manjusha, Shen, Biyi, Flink, Dina, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Cordoba, Raul
Publicado 2023

Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells

por Giladi, Moshe, Schneiderman, Rosa S, Voloshin, Tali, Porat, Yaara, Munster, Mijal, Blat, Roni, Sherbo, Shay, Bomzon, Zeev, Urman, Noa, Itzhaki, Aviran, Cahal, Shay, Shteingauz, Anna, Chaudhry, Aafia, Kirson, Eilon D, Weinberg, Uri, Palti, Yoram
Publicado 2015

PB2357: TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH SYSTEMIC THERAPY FROM REAL-WORLD EXPERIENCE (ORCHID)

por Thieblemont, Catherine, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, van Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Bachy, Emmanuel, Damaj, Gandhi Laurent
Publicado 2023

PB2281: TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN RELAPSED/REFRACTORY PATIENTS TREATED WITH SYSTEMIC THERAPY IN A REAL-WORLD ASSESSMENT (FLORA)

por Damaj, Gandhi Laurent, Bachy, Emmanuel, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, van Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Thieblemont, Catherine
Publicado 2023

P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2

por Taszner, Michał, Luminari, Stefano, Cho, Seok-Goo, Novelli, Silvana, Le Gouill, Steven, Poon, Michelle, Villasboas, Jose, Champion, Rebecca, Bachy, Emmanuel, Guidez, Stephanie, Alonso Alonso, Aránzazu, Jagadeesh, Deepa, Merli, Michele, Tucker, David, Cai, Jingxian, Leite de Oliveira, Carolina, Zhu, Min, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Min Kim, Tae
Publicado 2023

P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2

por Walewski, Jan, Min Kim, Tae, Cho, Seok-Goo, Jarque, Isidro, Iskierka-Jażdżewska, Elżbieta, Poon, Michelle, Miles Prince, H., Yong Oh, Sung, Lim, Francesca, Segura, Cecilia Carmen Carpio, Tan, Tran-Der, Ayyappan, Sabarish, Gutiérrez, Antonio, LI, Jingjin, Ufkin, Melanie, Zhu, Min, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Kim, Won-Seog
Publicado 2023